全文获取类型
收费全文 | 3510篇 |
免费 | 216篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 152篇 |
妇产科学 | 113篇 |
基础医学 | 538篇 |
口腔科学 | 59篇 |
临床医学 | 289篇 |
内科学 | 547篇 |
皮肤病学 | 120篇 |
神经病学 | 296篇 |
特种医学 | 105篇 |
外科学 | 510篇 |
综合类 | 102篇 |
预防医学 | 216篇 |
眼科学 | 125篇 |
药学 | 301篇 |
中国医学 | 23篇 |
肿瘤学 | 211篇 |
出版年
2023年 | 29篇 |
2022年 | 52篇 |
2021年 | 107篇 |
2020年 | 44篇 |
2019年 | 90篇 |
2018年 | 107篇 |
2017年 | 64篇 |
2016年 | 90篇 |
2015年 | 84篇 |
2014年 | 120篇 |
2013年 | 143篇 |
2012年 | 239篇 |
2011年 | 252篇 |
2010年 | 146篇 |
2009年 | 96篇 |
2008年 | 167篇 |
2007年 | 176篇 |
2006年 | 175篇 |
2005年 | 154篇 |
2004年 | 128篇 |
2003年 | 114篇 |
2002年 | 108篇 |
2001年 | 67篇 |
2000年 | 89篇 |
1999年 | 73篇 |
1998年 | 24篇 |
1997年 | 14篇 |
1996年 | 15篇 |
1995年 | 20篇 |
1994年 | 16篇 |
1993年 | 16篇 |
1992年 | 39篇 |
1991年 | 41篇 |
1990年 | 45篇 |
1989年 | 47篇 |
1988年 | 32篇 |
1987年 | 40篇 |
1986年 | 37篇 |
1985年 | 38篇 |
1984年 | 32篇 |
1983年 | 27篇 |
1982年 | 22篇 |
1981年 | 19篇 |
1980年 | 25篇 |
1979年 | 29篇 |
1978年 | 15篇 |
1977年 | 20篇 |
1976年 | 13篇 |
1975年 | 12篇 |
1973年 | 14篇 |
排序方式: 共有3739条查询结果,搜索用时 15 毫秒
991.
Liposomal drug delivery systems--clinical applications 总被引:1,自引:0,他引:1
Goyal P Goyal K Vijaya Kumar SG Singh A Katare OP Mishra DN 《Acta pharmaceutica (Zagreb, Croatia)》2005,55(1):1-25
Liposomes have been widely investigated since 1970 as drug carriers for improving the delivery of therapeutic agents to specific sites in the body. As a result, numerous improvements have been made, thus making this technology potentially useful for the treatment of certain diseases in the clinics. The success of liposomes as drug carriers has been reflected in a number of liposome-based formulations, which are commercially available or are currently undergoing clinical trials. The current pharmaceutical preparations of liposome-based therapeutic systems mainly result from our understanding of lipid-drug interactions and liposome disposition mechanisms. The insight gained from clinical use of liposome drug delivery systems can now be integrated to design liposomes that can be targeted on tissues, cells or intracellular compartments with or without expression of target recognition molecules on liposome membranes. This review is mainly focused on the diseases that have attracted most attention with respect to liposomal drug delivery and have therefore yielded most progress, namely cancer, antibacterial and antifungal disorders. In addition, increased gene transfer efficiencies could be obtained by appropriate selection of the gene transfer vector and mode of delivery. 相似文献
992.
993.
994.
995.
996.
Permeability of the blood-brain barrier to HIV-1 Tat 总被引:4,自引:0,他引:4
Infection with human immunodeficiency virus-1 (HIV-1) is associated with dysfunctions of the central nervous system (CNS). HIV-1 induces its effects on the CNS by a variety of mechanisms, including by shedding the neurotoxic viral proteins such as gp120 and Tat. Both HIV-1 and gp120 have been shown to cross the blood-brain barrier (BBB). It is has not been determined, however, whether blood-borne Tat can cross the BBB. Here, we found that Tat crosses the BBB by a nonsaturable mechanism with a unidirectional influx rate of about 0.490 microl/g/min. About 0.126% of an intravenous dose of Tat enters each g of brain. Radioactively labeled albumin injected simultaneously did not cross the BBB. The hypothalamus, occipital cortex, and hippocampus were the regions of the brain most permeable to Tat. Nonsaturable brain-to-blood efflux also occurred, most likely with reabsorption into the blood of the cerebrospinal fluid. In conclusion, we found that Tat crossed the BBB bidirectionally. Such permeability could provide a mechanism by which Tat produced on one side of the BBB could affect neural or immune function on the other side. 相似文献
997.
998.
Gohagan JK Marcus PM Fagerstrom RM Pinsky PF Kramer BS Prorok PC Ascher S Bailey W Brewer B Church T Engelhard D Ford M Fouad M Freedman M Gelmann E Gierada D Hocking W Inampudi S Irons B Johnson CC Jones A Kucera G Kvale P Lappe K Manor W Moore A Nath H Neff S Oken M Plunkett M Price H Reding D Riley T Schwartz M Spizarny D Yoffie R Zylak C;LUNG SCREENING STUDY RESEARCH GROUP 《Lung cancer (Amsterdam, Netherlands)》2005,47(1):9-15
The Lung Screening Study (LSS) was a pilot study designed to assess the feasibility of conducting a large scale randomized controlled trial (RCT) of low radiation dose spiral computed tomography (LDCT) versus chest X-ray (CXR) for lung cancer screening. Baseline results of LSS have been previously reported. Here, we report on the findings at the year one screen and on the final results of the LSS study. A total of 1660 subjects were randomized to the LDCT arm and 1658 to the CXR arm. Compliance with screening declined from 96% at baseline to 86% at year one in the LDCT arm and declined from 93% at baseline to 80% at year one in the CXR arm. Positivity rates for the year one screen were 25.8% for LDCT and 8.7% for CXR. Cancer yield was significantly less at year one for LDCT, 0.57%, than at baseline, 1.9%; cancer yield for CXR increased from 0.45% at baseline to 0.68% at year one. Forty lung cancers in the LDCT arm and 20 in the CXR arm were diagnosed over the study period. Stage I cancers comprised 48% of cases in the LDCT arm and 40% in the CXR arm. A total of 16 stage III-IV cancers were observed in the LDCT arm versus nine in the CXR arm. The LSS has established the feasibility of a RCT comparing annual spiral CT to chest X-ray for lung cancer screening. 相似文献
999.
1000.
A case of muscular hypertrophy in a hypothyroid 12-year-old male child, known as Kocher Debre Semelaigne syndrome, is reported with review of the relevant literature. The patient responded well to l-thyroxine therapy. 相似文献